HUMAN PAPILLOMAVIRUS DETECTION IN CERVICAL-CARCINOMA TISSUES AND PARAAORTIC LYMPH-NODES BY THE POLYMERASE CHAIN-REACTION

Citation
Js. Park et al., HUMAN PAPILLOMAVIRUS DETECTION IN CERVICAL-CARCINOMA TISSUES AND PARAAORTIC LYMPH-NODES BY THE POLYMERASE CHAIN-REACTION, Gynecologic oncology, 53(3), 1994, pp. 344-351
Citations number
31
Categorie Soggetti
Oncology,"Obsetric & Gynecology
Journal title
ISSN journal
00908258
Volume
53
Issue
3
Year of publication
1994
Pages
344 - 351
Database
ISI
SICI code
0090-8258(1994)53:3<344:HPDICT>2.0.ZU;2-U
Abstract
Tissues of 45 cervical cancers and paraaortic lymph nodes from the sam e patients were evaluated by polymerase chain reaction with L1 consens us primers and hybridization with type-specific oligomer probes of HPV -6, -11, -16, -18, -31, -33, -35, and -45 for the detection and classi fication of subtypes of human papillomavirus (HPV). The clinicohistolo gic findings of surgical specimens from radical hysterectomy were comp ared with the results of HPV detection to use as a possible prognostic marker for the early detection of paraaortic nodes involvement. Metas tasis to paraaortic nodes in cervical cancer, suggesting extrapelvic i nvolvement of tumor, is clinically important to predict prognosis. The HPV-16 DNA was most prevalent in cervical cancers (76%; 34/45). Five tumors were positive for HPV-18, two tumors each were positive for HPV -31 or -33, one tumor was hybridized to HPV-45, and one woman had an u nidentified type of HPV. No HPV was detected in three cases of cervica l cancer. The histologic types of the cervical cancers were correlated with the HPV types. Of the 39 tissue specimens of squamous carcinomas analyzed, only 2 (5%) showed HPV-18, in contrast to 30 (77%) of 39 sq uamous carcinomas having HPV-16. Of the 5 cases of adenocarcinomas, 3 (50%) showed HPV-18, and 3 (50%) showed HPV-16. HPV DNAs were detected in histologically negative paraaortic lymph nodes (31%; 14/45): the H PV-positive PCR products from paraaortic nodes were only hybridized to HPV-16. The nature of the relationship between the presence of HPV DN A and node tumor involvement is still not known. HPV-16 DNA in paraaor tic nodes may suggest subclinical early metastasis or tumor cells dest royed by immune cells and may provide important information in decisio ns regarding postoperative adjuvant treatment. The prognostic signific ance of HPV DNA in histologically negative paraaortic lymph nodes rema ins to be established after several years of follow-up.